Analysis of potential treatment of lymphangioleiomyomatosis patients based on a method derived from rates of decline in premenopausal patients with forced expiratory volume in 1 s (FEV1) or diffusing capacity of the lung for carbon monoxide (DLCO) >70% predicted
| Treated based on analytical method | |||
| Yes | No | Total | |
| FEV1 >70% | 12 (24.5) | 37 (75.5) | 49 (100.0) |
| DLCO >70% | 11 (24.4) | 34 (75.6) | 45 (100.0) |
Data are presented as n (%). Columns show the numbers of patients to be treated with mTOR (mechanistic target of rapamycin) inhibitors when the observed FEV1 and DLCO were lower than the expected values derived from rates of decline in FEV1 and DLCO.